Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
about
Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal AdenocarcinomaCorrigendum to "Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively"
P2860
Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@ast
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@en
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@nl
type
label
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@ast
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@en
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@nl
prefLabel
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@ast
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@en
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@nl
P2093
P2860
P50
P921
P356
P1476
Evaluation of Plasma MicroRNAs ...... gnostic Markers, Respectively.
@en
P2093
Changqing Xu
Chengfeng Wang
P2860
P304
P356
10.1155/2017/6495867
P407
P577
2017-03-29T00:00:00Z